Creso Pharma Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COPHF research report →
Companywww.cresopharma.com
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils.
- CEO
- William Lay
- IPO
- 2017
- HQ
- Nedlands, WA, AU
Price Chart
Valuation
- Market Cap
- $131.72M
- P/E
- -0.40
- P/S
- 2.66
- P/B
- 0.59
- EV/EBITDA
- -0.94
- Div Yield
- 21343333.33%
Profitability
- Gross Margin
- 3.30%
- Op Margin
- -225.19%
- Net Margin
- -377.28%
- ROE
- -130.99%
- ROIC
- -67.55%
Growth & Income
- Revenue
- $18.92M · 117.76%
- Net Income
- $-52,446,000 · -59.98%
- EPS
- $0.00 · 100.00%
- Op Income
- $-16,680,000
- FCF YoY
- 72.89%
Performance & Tape
- 52W High
- $9.47
- 52W Low
- $0.00
- 50D MA
- $0.12
- 200D MA
- $0.07
- Beta
- -24.81
- Avg Volume
- 0
Get TickerSpark's AI analysis on COPHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our COPHF Coverage
We haven't published any research on COPHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate COPHF Report →